The Hyper-IgE Syndromes: Lessons in Nature, From Bench to Bedside

Choi, 1996, Assignment of the acute phase response factor (APRF) gene to 17q21 by microdissection clone sequencing and fluorescence in situ hybridization of a P1 clone, Genomics, 37, 264, 10.1006/geno.1996.0556 Kisseleva, 2002, Signaling through the JAK/STAT pathway, recent advances and future challenges, Gene, 285, 1, 10.1016/S0378-1119(02)00398-0 Levy, 2002, Stats: transcriptional control and biological impact, Nat Rev Mol Cell Biol, 3, 651, 10.1038/nrm909 Wegrzyn, 2009, Function of mitochondrial Stat3 in cellular respiration, Science, 323, 793, 10.1126/science.1164551 Pelletier, 2003, Rho family GTPases are required for activation of Jak/STAT signaling by G protein coupled receptors, Mol Cell Biol, 23, 1316, 10.1128/MCB.23.4.1316-1333.2003 Heim, 2003, The STAT protein family, 11 Woellner, 2010, Mutations in STAT3 and diagnostic guidelines for hyper-IgE syndrome, J Allergy Clin Immunol, 125, 424, 10.1016/j.jaci.2009.10.059 Mintz, 2010, Reduced expression of chemoattractant receptors by polymorphonuclear leukocytes in Hyper IgE Syndrome patients, Immunol Lett, 130, 97, 10.1016/j.imlet.2009.12.006 Rossi, 2000, The biology of chemokines and their receptors, Annu Rev Immunol, 18, 217, 10.1146/annurev.immunol.18.1.217 Zeilhofer, 2000, Role of interleukin-8 in neutrophil signaling, Curr Opin Hematol, 7, 178, 10.1097/00062752-200005000-00009 Mukaida, 2000, Interleukin-8: an expanding universe beyond neutrophil chemotaxis and activation, Int J Hematol, 72, 391 Baggiolini, 1995, Interleukin-8 and the chemokine family, Int J Immunopharmacol, 17, 103, 10.1016/0192-0561(94)00088-6 Murphy, 1997, Neutrophil receptors for interleukin-8 and related CXC chemokines, Semin Hematol, 34, 311 Chuntharapai, 1995, Regulation of the expression of IL-8 receptor A/B by IL-8: possible functions of each receptor, J Immunol, 155, 2587, 10.4049/jimmunol.155.5.2587 Richardson, 1998, Differential cross-regulation of the human chemokine receptors CXCR1 and CXCR2. Evidence for time-dependent signal generation, J Biol Chem, 273, 23830, 10.1074/jbc.273.37.23830 Green, 1996, Interleukin-8 (IL-8), melanoma growth-stimulatory activity, and neutrophil-activating peptide selectively mediate priming of the neutrophil NADPH oxidase through the type A or type B IL-8 receptor, J Biol Chem, 271, 25400, 10.1074/jbc.271.41.25400 Feniger-Barish, 2003, IL-8-induced migratory responses through CXCR1 and CXCR2: association with phosphorylation and cellular redistribution of focal adhesion kinase, Biochemistry, 42, 2874, 10.1021/bi026783d Feniger-Barish, 1999, Differential modes of regulation of cxc chemokine-induced internalization and recycling of human CXCR1 and CXCR2, Cytokine, 11, 996, 10.1006/cyto.1999.0510 Richardson, 1998, Multiple signaling pathways of human interleukin-8 receptor A. Independent regulation by phosphorylation, J Biol Chem, 273, 10690, 10.1074/jbc.273.17.10690 Hammond, 1995, IL-8 induces neutrophil chemotaxis predominantly via type I IL-8 receptors, J Immunol, 155, 1428, 10.4049/jimmunol.155.3.1428 Van Damme, 1997, Granulocyte chemotactic protein-2 and related CXC chemokines: from gene regulation to receptor usage, J Leukoc Biol, 62, 563, 10.1002/jlb.62.5.563 Zlotnik, 2006, The chemokine and chemokine receptor superfamilies and their molecular evolution, Genome Biol, 7, 243, 10.1186/gb-2006-7-12-243 Minegishi, 2009, Molecular explanation for the contradiction between systemic Th17 defect and localized bacterial infection in hyper-IgE syndrome, J Exp Med, 206, 1291, 10.1084/jem.20082767 Conti, 2011, New mechanism of oral immunity to mucosal candidiasis in hyper-IgE syndrome, Mucosal Immunol, 4, 448, 10.1038/mi.2011.5 Siegel, 2011, A critical role for STAT3 transcription factor signaling in the development and maintenance of human T cell memory, Immunity, 35, 806, 10.1016/j.immuni.2011.09.016 Ozaki, 2002, A critical role for IL-21 in regulating immunoglobulin production, Science, 298, 1630, 10.1126/science.1077002 Wood, 2004, IL-21 effects on human IgE production in response to IL-4 or IL-13, Cell Immunol, 231, 133, 10.1016/j.cellimm.2005.01.001 Avery, 2010, B cellintrinsic signaling through IL-21 receptor and STAT3 is required for establishing long-lived antibody responses in humans, J Exp Med, 207, 155, 10.1084/jem.20091706 Speckmann, 2008, Reduced memory B cells in patients with hyper IgE syndrome, Clin Immunol, 129, 448, 10.1016/j.clim.2008.08.002 Meyer-Bahlburg, 2012, Heterozygous signal transducer and activator of transcription 3 mutations in hyper-IgE syndrome result in altered B-cell maturation, J Allergy Clin Immunol, 129, 559, 10.1016/j.jaci.2011.09.017 Sekhsaria, 2011, Plasma metalloproteinase levels are dysregulated in signal transducer and activator of transcription 3 mutated hyper-IgE syndrome, J Allergy Clin Immunol, 128, 1124, 10.1016/j.jaci.2011.07.046 Zhou, 2011, Osteoblast/osteocyte-specific inactivation of Stat3 decreases load-driven bone formation and accumulates reactive oxygen species, Bone, 49, 404, 10.1016/j.bone.2011.04.020 Lufei, 2003, GRIM-19, a death-regulatory gene product, suppresses Stat3 activity via functional interaction, EMBO J, 22, 1325, 10.1093/emboj/cdg135 Griggs, 2008, Dedicator of cytokinesis 8 is disrupted in two patients with mental retardation and developmental disabilities, Genomics, 91, 195, 10.1016/j.ygeno.2007.10.011 Zhang, 2010, Genetic, clinical, and laboratory markers for DOCK8 immunodeficiency syndrome, Dis Markers, 29, 131, 10.1155/2010/972591 Raptis, 2011, The R(h)oads to Stat3: Stat3 activation by the Rho GTPases, Exp Cell Res, 317, 1787, 10.1016/j.yexcr.2011.05.008 Debidda, 2005, A role of STAT3 in Rho GTPase-regulated cell migration and proliferation, J Biol Chem, 280, 17275, 10.1074/jbc.M413187200 Faruqi, 2001, Rac1 mediates STAT3 activation by autocrine IL-6, Proc Natl Acad Sci USA, 98, 9014, 10.1073/pnas.161281298 Simon, 2000, Regulation of STAT3 by direct binding to the Rac1 GTPase, Science, 290, 144, 10.1126/science.290.5489.144 Engelhardt, 2009, Large deletions and point mutations involving the dedicator of cytokinesis 8 (DOCK8) in the autosomal-recessive form of hyper-IgE syndrome, J Allergy Clin Immunol, 124, 1289, 10.1016/j.jaci.2009.10.038 Cote, 2007, GEF what? Dock180 and related proteins help Rac to polarize cells in new ways, Trends Cell Biol, 17, 383, 10.1016/j.tcb.2007.05.001 Randall, 2011, DOCK8 deficiency impairs CD8 T cell survival and function in humans and mice, J Exp Med, 208, 2305, 10.1084/jem.20110345 Zhang, 2009, Combined immunodeficiency associated with DOCK8 mutations, N Engl J Med, 361, 2046, 10.1056/NEJMoa0905506 Al Khatib, 2009, Defects along the T(H)17 differentiation pathway underlie genetically distinct forms of the hyper IgE syndrome, J Allergy Clin Immunol, 124, 342, 10.1016/j.jaci.2009.05.004 Lambe, 2011, DOCK8 is essential for T-cell survival and the maintenance of CD8(+) T-cell memory, Eur J Immunol, 41, 3423, 10.1002/eji.201141759 Randall, 2009, Dock8 mutations cripple B cell immunological synapses, germinal centers and long-lived antibody production, Nat Immunol, 10, 1283, 10.1038/ni.1820 Firmbach-Kraft, 1990, tyk2, prototype of a novel class of non-receptor tyrosine kinase genes, Oncogene, 5, 1329 Trask, 1993, Fluorescence in situ hybridization mapping of human chromosome 19: cytogenetic band location of 540 cosmids and 70 genes or DNA markers, Genomics, 15, 133, 10.1006/geno.1993.1021 Krolewski, 1990, Identification and chromosomal mapping of new human tyrosine kinase genes, Oncogene, 5, 277 Finbloom, 1995, IL-10 induces the tyrosine phosphorylation of tyk2 and Jak1 and the differential assembly of STAT1 alpha and STAT3 complexes in human T cells and monocytes, J Immunol, 155, 1079, 10.4049/jimmunol.155.3.1079 Ho, 1995, Functional regions of the mouse interleukin-10 receptor cytoplasmic domain, Mol Cell Biol, 15, 5043, 10.1128/MCB.15.9.5043 Kopantzev, 2002, IL-6 mediated activation of STAT3 bypasses Janus kinases in terminally differentiated B lineage cells, Oncogene, 21, 6791, 10.1038/sj.onc.1205815 Ihle, 1995, Jaks and Stats in signaling by the cytokine receptor superfamily, Trends Genet, 11, 69, 10.1016/S0168-9525(00)89000-9 Welham, 1995, Interleukin-13 signal transduction in lymphohemopoietic cells. Similarities and differences in signal transduction with interleukin-4 and insulin, J Biol Chem, 270, 12286, 10.1074/jbc.270.20.12286 Stahl, 1994, Association and activation of Jak-Tyk kinases by CNTF-LIF-OSM-IL-6 beta receptor components, Science, 263, 92, 10.1126/science.8272873 Narazaki, 1994, Activation of JAK2 kinase mediated by the interleukin 6 signal transducer gp130, Proc Natl Acad Sci USA, 91, 2285, 10.1073/pnas.91.6.2285 Du, 1997, Interleukin-11: review of molecular, cell biology, and clinical use, Blood, 89, 3897, 10.1182/blood.V89.11.3897 Trinchieri, 2003, The IL-12 family of heterodimeric cytokines: new players in the regulation of T cell responses, Immunity, 19, 641, 10.1016/S1074-7613(03)00296-6 Chishti, 1998, The FERM domain: a unique module involved in the linkage of cytoplasmic proteins to the membrane, Trends Biochem Sci, 23, 281, 10.1016/S0968-0004(98)01237-7 Pearson, 2000, Structure of the ERM protein moesin reveals the FERM domain fold masked by an extended actin binding tail domain, Cell, 101, 259, 10.1016/S0092-8674(00)80836-3 Marengere, 1994, Structure and function of SH2 domains, J Cell Sci Suppl, 18, 97, 10.1242/jcs.1994.Supplement_18.14 Pawson, 1995, Protein modules and signalling networks, Nature, 373, 573, 10.1038/373573a0 Mayer, 1993, Signalling through SH2 and SH3 domains, Trends Cell Biol, 3, 8, 10.1016/0962-8924(93)90194-6 Pawson, 1993, SH2 and SH3 domains, Curr Biol, 3, 434, 10.1016/0960-9822(93)90350-W Manning, 2002, Evolution of protein kinase signaling from yeast to man, Trends Biochem Sci, 27, 514, 10.1016/S0968-0004(02)02179-5 Minegishi, 2006, Human tyrosine kinase 2 deficiency reveals its requisite roles in multiple cytokine signals involved in innate and acquired immunity, Immunity, 25, 745, 10.1016/j.immuni.2006.09.009 Ishizaki, 2011, Involvement of tyrosine kinase-2 in both the IL-12/Th1 and IL-23/Th17 axes in vivo, J Immunol, 187, 181, 10.4049/jimmunol.1003244 Freeman, 2009, Hyper IgE (Job's) syndrome: a primary immune deficiency with oral manifestations, Oral Dis, 15, 2, 10.1111/j.1601-0825.2008.01463.x Freeman, 2009, Clinical manifestations, etiology, and pathogenesis of the hyper-IgE syndromes, Pediatr Res, 65, 32R, 10.1203/PDR.0b013e31819dc8c5 Vinh, 2010, Invasive fungal disease in autosomal-dominant hyper-IgE syndrome, J Allergy Clin Immunol, 125, 1389, 10.1016/j.jaci.2010.01.047 Melia, 2009, Pulmonary nontuberculous mycobacterial infections in hyper-IgE syndrome, J Allergy Clin Immunol, 124, 617, 10.1016/j.jaci.2009.07.007 Ma, 2009, Recurrent hemoptysis with Penicillium marneffei and Stenotrophomonas maltophilia in Job's syndrome, Can Respir J, 16, e50, 10.1155/2009/586919 Netea, 2002, Th1/Th2 cytokine imbalance in a family with hyper-IgE syndrome, Neth J Med, 60, 349 Yavuz, 2010, A review on the vascular features of the hyperimmunoglobulin E syndrome, Clin Exp Immunol, 159, 238, 10.1111/j.1365-2249.2009.04044.x Freeman, 2011, Coronary artery abnormalities in hyper-IgE syndrome, J Clin Immunol, 31, 338, 10.1007/s10875-011-9515-9 Gharib, 2009, Coronary abnormalities in hyper-IgE recurrent infection syndrome: depiction at coronary MDCT angiography, AJR Am J Roentgenol, 193, W478, 10.2214/AJR.09.2623 Stover, 2010, Diverticulitis in a young man with hyper-IgE syndrome, South Med J, 103, 1261, 10.1097/SMJ.0b013e3181fa5f0e Chen, 1995, Colon perforation in a patient with hyperimmunoglobulin E (Job's) syndrome, J Pediatr Surg, 30, 1479, 10.1016/0022-3468(95)90412-3 Hwang, 1998, Colon perforation in hyperimmunoglobulin E syndrome, J Pediatr Surg, 33, 1420, 10.1016/S0022-3468(98)90025-2 Steiner, 2009, Ileocecal histoplasmosis simulating Crohn disease in a patient with hyperimmunoglobulin E syndrome, Pediatr Infect Dis J, 28, 744, 10.1097/INF.0b013e31819b65e0 Cappell, 1991, Recurrent colonic histoplasmosis after standard therapy with amphotericin B in a patient with Job's syndrome, Am J Gastroenterol, 86, 119 Leonard, 2004, Non-Hodgkin's lymphoma in Job's syndrome: a case report and literature review, Leuk Lymphoma, 45, 2521, 10.1080/10428190400004463 Kumanovics, 2010, Diffuse large B cell lymphoma in hyper-IgE syndrome due to STAT3 mutation, J Clin Immunol, 30, 886, 10.1007/s10875-010-9452-z Belada, 2010, Diffuse large B-cell lymphoma in a patient with hyper-IgE syndrome: successful treatment with risk-adapted rituximab-based immunochemotherapy, Leuk Res, 34, e232, 10.1016/j.leukres.2010.01.024 Renner, 2004, Autosomal recessive hyperimmunoglobulin E syndrome: a distinct disease entity, J Pediatr, 144, 93, 10.1016/S0022-3476(03)00449-9 Kilic SS, Hacimustafaoglu M, Boisson-Dupuis S, Kreins AY, Grant AV, Abel L, Casanova JL. A patient with tyrosine kinase 2 deficiency without hyper-IgE syndrome. J Pediatr. 2012; [Published ahead of print March 6, 2012]. Grimbacher, 1999, Genetic linkage of hyper-IgE syndrome to chromosome 4, Am J Hum Genet, 65, 735, 10.1086/302547 Schimke, 2010, Diagnostic approach to the hyper-IgE syndromes: immunologic and clinical key findings to differentiate hyper-IgE syndromes from atopic dermatitis, J Allergy Clin Immunol, 126, 611, 10.1016/j.jaci.2010.06.029 Heimall, 2011, Paucity of genotype-phenotype correlations in STAT3 mutation positive hyper IgE syndrome (HIES), Clin Immunol, 139, 75, 10.1016/j.clim.2011.01.001 Ochs HD, Smith CIE, Puck J Primary Immunodeficiency Diseases: A Molecular and Genetic Approach. New York, NY: Oxford University Press; 2007. Kumanovics, 2010, Rapid molecular analysis of the STAT3 gene in Job syndrome of hyper-IgE and recurrent infectious diseases, J Mol Diagn, 12, 213, 10.2353/jmoldx.2010.090080 Dasouki, 2011, Deficient T cell receptor excision circles (TRECs) in autosomal recessive hyper IgE syndrome caused by DOCK8 mutation: implications for pathogenesis and potential detection by newborn screening, Clin Immunol, 141, 128, 10.1016/j.clim.2011.06.003 Freeman, 2008, The hyper-IgE syndromes, Immunol Allergy Clin North Am, 28, 277, 10.1016/j.iac.2008.01.005 Freeman, 2010, Clinical manifestations of hyper IgE syndromes, Dis Markers, 29, 123, 10.1155/2010/580197 Bittner, 2010, Successful long-term correction of autosomal recessive hyper-IgE syndrome due to DOCK8 deficiency by hematopoietic stem cell transplantation, Klin Padiatr, 222, 351, 10.1055/s-0030-1265135 McDonald, 2010, Successful engraftment of donor marrow after allogeneic hematopoietic cell transplantation in autosomal-recessive hyper-IgE syndrome caused by dedicator of cytokinesis 8 deficiency, J Allergy Clin Immunol, 126, 1304, 10.1016/j.jaci.2010.07.034 Gatz, 2011, Curative treatment of autosomal-recessive hyper-IgE syndrome by hematopoietic cell transplantation, Bone Marrow Transplant, 46, 552, 10.1038/bmt.2010.169 Gennery, 2000, Bone marrow transplantation does not correct the hyper IgE syndrome, Bone Marrow Transplant, 25, 1303, 10.1038/sj.bmt.1702446